NCT05007756View on ClinicalTrials.gov

A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of Interest

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

November 4, 2021

Study Completion Date

November 4, 2021

Conditions
Healthy
Interventions
RADIATION

UVB Challenge

UVB challenge will be administered dermally through Lumera Phototherapy System.

Trial Locations (1)

2170

Clinical Pharmacology Unit, Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY